Search Results
Search results for "VIB-VUB Center for Structural Biology"
Results found for "VIB-VUB Center for Structural Biology"
- đź“° GPCR Weekly News, October 30 to November 4, 2023
Study of G protein-coupled receptors dimerization: From bivalent ligands to drug-like small molecules Structural Orexin Receptor Antagonist for the Treatment of Insomnia OMass Therapeutics Releases First Protein Structures in PDB, Advances Lupus Therapy Research Structure Therapeutics Receives R&D Achievement of the Year
- Functional Characterization of the Venus Flytrap Domain of the Human TAS1R2 Sweet Taste Receptor
dichroism spectroscopic studies revealed that hTAS1R2-VFT was properly folded with evidence of secondary structures quantities of hTAS1R2-VFT to further characterize the mechanism of binding interaction and perform structural
- Research Network on Signal Transduction (ERNEST) has established an Emergency Fund for Ukrainian ...
Researchers affiliated to any legal entity in Ukraine (for example, schools and universities, research centers
- A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in...
adhesion GPCRs), as a member of the G protein-coupled receptors (GPCRs) superfamily, have gradually entered The structure, function, and involvement of adhesion GPCRs in cancer development have been discussed
- đź“° GPCR Weekly News, April 15 to 21, 2024
GPCR Symposia Join us on June 7th for our symposium on Structural and Molecular Insights into GPCR Function Phosphorylation and G-Protein Mediated Signaling Networks June 25 - 29, 2024 | FENS Forum 2024 October 2024 | Biologics
- Why Kinetics Matter More Than Kd in GPCR Drug Discovery
Breakthroughs this week: Structure-based discovery of positive allosteric modulators of the A1 adenosine Premium classified content — designed to keep you ahead without noise or delays: Industry insights:  Structure-Based
- A Model for the Signal Initiation Complex Between Arrestin-3 and the Src Family Kinase Fgr
To provide a framework for this interaction, we determined the crystal structure of the Fgr SH3 domain Collectively, these studies provide a structural framework for arrestin-dependent activation of Fgr.
- Advantages of Fluorescent Probes in GPCR Assays
They can also further pharmacological and structural studies, as they can be used to determine receptor The dyes might have charges or be so hydrophilic/hydrophobic that they bind to intracellular structures
- Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology
few years ago by some former colleagues and their description of the company was very intriguing: a biology
- On-cell nuclear magnetic resonance spectroscopy to probe cell surface interactions
spectroscopy allows the determination of atomic-level information on intermolecular interactions, molecular structure ligands involved in binding, ligand bound-state conformational determination, evaluation of receptor structuring
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
prepare to present  often miss the deeper expectation: the FDA is not just listening, it is probing for structural While founders try to demonstrate confidence, the FDA is systematically looking for structural weak points
- Dual loss of regulator of G protein signaling 2 and 5 exacerbates ventricular myocyte arrhythmias...
Here we examined how the dual absence of RGS2 and 5 (Rgs2/5 dbKO) affects blood pressure and cardiac structure
- What If the Most Important Part of Your Drug Isn’t What It Binds—But What It Does?
uncover why efficacy is the unsung hero of drug discovery and how its effects depend entirely on the biological
- Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate ...
Company”; TSE: 4565), an international biopharmaceutical company and world-leader in GPCR1-focused structure-based
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
GPCR ligands pharmacology The impact of a ligand on a receptor's structure and biophysical attributes , and consequently on the biological response, is referred to as ligand efficacy.
- Addex Therapeutics To Release Full-Year 2021 Financial Results And Host Conference Call On March 10
Tim Dyer, CEO, Roger Mills, CMO and Robert LĂĽtjens, Head of Discovery Biology, will provide a business
- Molecular insights into regulation of constitutive activity by RNA editing 5HT2C serotonin receptor
responsible for these effects of RNA editing, we present four active-state 5HT2C-transducer-coupled structures
- A2A Fluorescent Competitive Binding: Advancing NanoBRET® Target Engagement for GPCR Drug Discovery
technology significantly reduces the time it takes to obtain fluorescent tags and test varying linker structures As seen in figure 2, a heterogenous set of compounds  (agonists and antagonists, different structures
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
The Journal of membrane biology, 254(3), 259–271. https://doi.org/10.1007/s00232-020-00158-7 Gonçalves-Monteiro Nature chemical biology, 5(10), 734–742. https://doi.org/10.1038/nchembio.206 Wei, H., Ahn, S., Shenoy Nature chemical biology, 13(7), 799–806. https://doi.org/10.1038/nchembio.2389 Godbole, A., Lyga, S.,
- GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generation
Collectively, these studies provide insight into the molecular and structural determinants of the APH1A-βarr2
- Odorant receptors – a bit of smell for drug discovery
Selective screening assays for ectopic ORs as well as investment on the structural characterization of function of ORs in vivo, development of in vitro systems for functional assays and the availability of structural information for structure-based drug design.
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
Here, we review how nanobodies have been adopted to elucidate the structure, pharmacology, and signaling
- Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
Dimensionality reduction analysis shows that Nb80 stabilizes structural features of the β2AR with an intracellular binding partners on the GPCR activation mechanism, which should be taken into account in structure-based
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
This solved a long-standing problem in GPCR biology: You can't understand signaling if you can’t seeÂ
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
Here, we report the structure-based development of fluorescent ligands targeting the intracellular allosteric
- Functional modulation of PTH1R activation and signaling by RAMP2
Employing homology modeling, we describe the putative structural molecular basis underlying our functional
- A broad look into the future of systemic sclerosis
The authors provide a hierarchical structure into the studies of the pathogenesis of SSc starting with
- Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System
We will discuss the historic context of pepducin development for each receptor, as well as the structural
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
And every time your Head of Biology spends each night copy-pasting data instead of thinking about the
- Biotech Startup Failure: Why Teams Drift Off Course Without a Single Wrong Decision
By the time leadership senses friction, the underlying causes are already structural. 👉 Biotech startup It is structural. 👉 Biotech startup failure of this kind is difficult to spot precisely because nothing









